logo-loader
RNS
viewGlaxoSmithKline PLC

Emma Walmsley - External Appointment

/**/ .w{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.w{}p.ag{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height: normal; margin-bottom: 0cm; text-align: center}span.ah{color: #333333; font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}p.ai{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: center}span.ac{font-size:10.0pt}span.aj{font-size: 10.0pt;font-family:"Arial","sans-serif";color:#333333}p.ak{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}span.al{font-size:10.0pt;font-family:"Arial","sans-serif"; color:#333333}span.am{font-size:10.0pt;font-family:"Arial","sans-serif"; color:#333333} span.an{color: #333333; font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}span.ao{color: #333333; font-family: "Arial","sans-serif"; font-size: 10.0pt; font-weight: bold}p.ap{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm}span.aq{font-size:10.0pt;font-family:"Arial","sans-serif"; color:#333333}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";} /**/
RNS Number : 7248V
GlaxoSmithKline PLC
04 December 2019
 

GlaxoSmithKline plc

 

Emma Walmsley - External Appointment

 

GlaxoSmithKline plc announces, pursuant to the Financial Conduct Authority's Listing Rule 9.6.14R, that Emma Walmsley, Chief Executive Officer, has been appointed as a non-executive director of Microsoft Corp ("Microsoft") with effect from 4 December 2019. 

 

Microsoft is a global technology company listed on Nasdaq.

 

 

V A Whyte

Company Secretary

 

4 December 2019

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RDNDZLFBKLFXFBF

Quick facts: GlaxoSmithKline PLC

Price: 1846

Market: LSE
Market Cap: £92.11 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Director/PDMR Shareholding

2 days, 14 hours ago

Director/PDMR Shareholding

3 days, 5 hours ago

Director/PDMR Shareholding

3 days, 5 hours ago

Director/PDMR Shareholding

4 days, 3 hours ago

Director/PDMR Shareholding

4 days, 10 hours ago

Director/PDMR Shareholding

4 days, 10 hours ago

Director/PDMR Shareholding

4 days, 11 hours ago